🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Tozaro appoints Dr Jason Slingsby MBA as CEO. Jason will lead the Company as it continues to capitalise on early momentum, harnessing its 'Smart Polymer' technology to enhance downstream manufacturing of viral vectors. Read the full press release: bit.ly/3Sd6lbU

.PlaqueTec Ltd today announced new research findings from interim data analysis of its ongoing BIOPATTERN trial. The findings provide early confidence in PlaqueTec’s approach to endotype #CoronaryArteryDisease as the trial progresses. Read more here: rb.gy/64b7sx

.Trilobio today announced it has raised $8M #seedfunding through an oversubscribed round led by Initialized Capital Capital, and participation from Argon Ventures and Lowercarbon Capital to support the expansion of the Trilobio Platform’s capabilities: shorturl.at/k8VeQ

Today Nuclera announced a new distribution network spanning the Asia-Pacific and Middle East regions, marking a major step forward in its global commercial strategy. Read more: shorturl.at/iImY7

Today PhoreMost announced the appointments of Barbara Duncan as Chair and Stephen Dilly as Non-Executive Director of its Board, bringing leadership expertise to advance its degrader pipeline and the commercialisation of its GlueSEEKER® platform. More: shorturl.at/u7Xdr

Great to be back in Aberdeen today, working at the BioHub and catching up with some familiar faces! 🏴󠁧󠁢󠁳󠁣󠁴󠁿

Today Tozaro announced the formation of its Technical Advisory Board. Phil Vanek, Carl Schoellhammer, Daniel C Smith and Nick Clarkson are members of the TAB and will support commercialisation of smart polymers in cell and gene therapy bioprocessing. bit.ly/4jj9iTD

Organ-on-a-chip (OOC) systems and solutions company, CN Bio Innovations has today announced a new distributor agreement with SCINCO, a specialist scientific instrument company based in South Korea, strengthening the Company's presence in major APAC markets. More: bit.ly/3H0tMmt

Shift Bioscience appoints Lord David Prior, previously Chairman of NHS England, and Sir Tony Kouzarides, co-founder of the Milner Therapeutics Institute and Abcam, to support long-term strategy for cell rejuvenation therapeutics. Read more: bit.ly/4kpyad5

Today Closed Loop Medicine announced the appointment of Kate Woolland as CEO, stepping into the role as the company shifts its focus to strategic commercial deployment and scaling of its precision dosing technologies. Read more: rb.gy/o2wp56

Today Sapio Sciences announced the appointment of Gordon McCall as Chief Operating Officer. Gordon will lead global customer delivery teams, manage customer relationships, and oversee operational functions to drive customer delivery and satisfaction. bit.ly/4kDzPvP

Today Nuclera announced a collaboration with Cytiva. This collaboration combines Nuclera’s eProtein Discovery with Cytiva’s Biacore SPR system to accelerate the synthesis and characterisation of proteins implicated in drug development. More: eprote.in/Colab.

Fujifilm has announced a rebranding for its Life Science Companies, including @irvinesci and @FujifilmDiosyn, to strengthen the Companies' positions as strategic partners for life. Read the full press release: bit.ly/3T8txs8

Today Shift Bioscience announced the publication of new research identifying a novel single-gene target for cellular rejuvenation. SB000 reverses cellular aging across multiple cell types without inducing dangerous pluripotency pathways. Learn more➡️rb.gy/sweg7z

Today CN Bio Innovations introduced cross species DILI services to its Contract Research Services. Extending the capabilities of the Company’s PhysioMimix DILI assay, these services will enhance in vitro to in vivo extrapolation during preclinical drug development. bit.ly/3TigTHc

Enhanced Genomics today announced the appointment of Dietrich Stephan, Ph.D. as Chair to lead the management team in implementing the Company’s plans to drive expansion of its internal target identification pipeline and establish strategic partnerships ➡️ rb.gy/ynmvz7

Centauri Therapeutics has published a peer-reviewed study in the Journal of Immunology, presenting the first pre-clinical application of endogenous antibody recruitment to address multi-drug resistant Gram-negative infections. Read the full press release: rb.gy/2a8n5q

This week, @tagomics has been awarded £860k Innovate UK funding as part of the Biomedical Catalyst grant for a £1.2M project to customise its multiomic profiling platform, Interlace, for the early detection of colorectal cancer. Read more: tagomics.com/tagomics-award…

.Kadans Science Partner has completed construction of the primary structure of Merlin Place, Cambridge, a purpose-built laboratory facility designed to encourage collaboration and advance life sciences and health innovation. Read more: kadans.com/news/structura…

Today SolasCure announced that the FDA has granted Fast Track Designation for its investigational Aurase Wound Gel, in the treatment of patients with calciphylaxis ulcers, widening its application in the healing of chronic wounds. Read more: rb.gy/zyb2qo